Middle East And Africa Glycobiology Market Worth to reach USD 120.28 million by 2023
Middle East And Africa Glycobiology Market - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
(EMAILWIRE.COM, November 23, 2018 ) Market Trends:
Market Data Forecast has released a report on Middle East and Africa Glycobiology market; Instruments and Kits market segment is expected to be fastest growing section of the market due to Advancements in glycomics instruments technology and growing investments on research & development by government. Drug Discovery segment is likely to hold key share in the market due to growing investments on research & development by government along with rising focus of pharmaceutical and biotechnology companies on novel drug development.
Middle East and Africa Glycobiology Market was worth USD 67.92 million in 2018 and estimated to be growing at a CAGR of 12.1%, to reach USD 120.28 million by 2023.
Some of other major companies dominating the market, by their products are Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).
Request for Sample @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/request-sample
Recent Developments:
Agilent is one of the leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Agilent Technologies Inc. announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for pre-implantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), translocations (PGT-SR), and aneuploidies (PGT-A) on a single biopsy. Agilent will showcase the OnePGT solution at the 5th Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN).
Agilent Technologies Inc. recently announced it has completed the acquirement of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/
Key Takeaways from this Report:
· For different product types, end-use applications and industry verticals, offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the market potential.
· Identify various driving factors, constraints and untold opportunities that can impact the global marketplace
· Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
· Increase overall revenue by understanding the geographical impact on sales and distribution channels.
· Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
· Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
· Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide market in over 20 top nations.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Market Data Forecast has released a report on Middle East and Africa Glycobiology market; Instruments and Kits market segment is expected to be fastest growing section of the market due to Advancements in glycomics instruments technology and growing investments on research & development by government. Drug Discovery segment is likely to hold key share in the market due to growing investments on research & development by government along with rising focus of pharmaceutical and biotechnology companies on novel drug development.
Middle East and Africa Glycobiology Market was worth USD 67.92 million in 2018 and estimated to be growing at a CAGR of 12.1%, to reach USD 120.28 million by 2023.
Some of other major companies dominating the market, by their products are Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).
Request for Sample @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/request-sample
Recent Developments:
Agilent is one of the leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Agilent Technologies Inc. announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for pre-implantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), translocations (PGT-SR), and aneuploidies (PGT-A) on a single biopsy. Agilent will showcase the OnePGT solution at the 5th Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN).
Agilent Technologies Inc. recently announced it has completed the acquirement of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/
Key Takeaways from this Report:
· For different product types, end-use applications and industry verticals, offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the market potential.
· Identify various driving factors, constraints and untold opportunities that can impact the global marketplace
· Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
· Increase overall revenue by understanding the geographical impact on sales and distribution channels.
· Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
· Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
· Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide market in over 20 top nations.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/mea-glycobiology-market-6986/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results